Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT03503708

Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease

Antioxidant for Improvement of Hepatic Function in Patients With Alcohol Liver Disease Without Cirrhosis: Non-randomized Interventional Cohort Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Composite Interceptive Med Science · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.

Conditions

Interventions

TypeNameDescription
DRUGLivitol-70Livitol-17 detoxifies, purifies and rejuvenates liver, kidney and spleen. Participants will be given the intervention in two bottles at each visit. Participant will be instructed to take two capsule twice daily at a fixed time in the day.

Timeline

Start date
2018-05-30
Primary completion
2018-10-30
Completion
2028-11-30
First posted
2018-04-20
Last updated
2018-04-20

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03503708. Inclusion in this directory is not an endorsement.